Randomized phases II study of WT1 peptide vaccine in combination with gemcitabine for advanced pancreaticcancer: association between clinical efficacy and immune response in metastatic pancreatic cancer patinets.
Randomized phases II study of WT1 peptide vaccine in combination with gemcitabine for advanced pancreaticcancer: association between clinical efficacy and immune response in metastatic pancreatic cancer patinets.
复制标题
WT1 肽疫苗联合吉西他滨治疗晚期胰腺癌的随机 II 期研究：转移性胰腺癌患者的临床疗效与免疫反应之间的关联。
DOI：
--
复制
发表时间：
2018
期刊：
影响因子：
--
通讯作者：
Haruo Sugiyama
中科院分区：
文献类型：
--
作者：
Sumiyuki Nishida;Soyoko Morimoto;Yoshihiro Oka;Shinichi Egawa;Takeshi Ishikawa; Shigeo Koido;Hiroaki Yasuda;Hiroaki Yanagimoto;Jun Ishii;Yoshihide Kanno;Atsushi Kumanogoh;Satoshi Morita;Haruo Sugiyama
